Stock Fundamentals

Company Information

Company Name
Arbutus Biopharma Corp
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: CA03879J1003
CIK: 0001447028
CUSIP: 87911B209
Currency: USD
Full Time Employees: 19
Phone: 267 469 0914
Fiscal Year End: December
IPO Date: Aug 03, 2015
Description:

Arbutus Biopharma Corporation, a clinical-stage biopharmaceutical company, develops novel therapeutics for infectious disease in the United States. Its chronic Hepatitis B virus product pipeline comprises Imdusiran, conjugated GalNAc, subcutaneously-delivered RNAi therapeutic product candidate which is in phase 2a clinical trials that suppresses all HBV antigens, including HBsAg expression; and AB-101, an oral PD-L1 inhibitor, which is in phase 1a/1b clinical trial that has the potential to reawaken patients' HBV-specific immune response by inhibiting PD-L1. The company has licensing agreement with Alnylam Pharmaceuticals, Inc. to develop and commercialize products with LNP delivery technology. The company was formerly known as Tekmira Pharmaceuticals Corporation and changed its name to Arbutus Biopharma Corporation in July 2015. Arbutus Biopharma Corporation was incorporated in 2005 is headquartered in Warminster, Pennsylvania.

Address:

701 Veterans Circle, Warminster, PA, United States, 18974

Directors & Officers

Name Title Year Born
Ms. Lindsay Androski J.D., M.B.A. President, CEO & Chairman 1977
Mr. Tuan Nguyen Chief Financial Officer 1976
Mr. Andrew J. Sung General Counsel NA
Mr. R. Hector Mackay-Dunn B.A., J.D., L.L.B., Q.C. Corporate Secretary 1951

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Feb 09, 2021 Michael J Mcelhaugh N/A Sale 20.00K $5.00 $100.00K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Morgan Stanley - Brokerage Accounts 25.89M Mar 31, 2026 13.15% $0.01 -3.04%
Two Seas Capital LP 18.56M Mar 31, 2026 9.42% $1.17 47.41%
Whitefort Capital Management, LP. 14.93M Mar 31, 2026 7.58% $19.81 11.90%
BlackRock Inc 12.97M Mar 31, 2026 6.58% $0.00 -0.66%
Vanguard Group Inc 9.24M Dec 31, 2025 4.69% $0.00 2.80%
Rubric Capital Management LP 6.63M Mar 31, 2026 3.36% $0.32 320.62%
State Street Corp 6.34M Mar 31, 2026 3.22% $0.00 7.35%
Barclays PLC 4.32M Mar 31, 2026 2.19% $0.00 1,110.06%
Geode Capital Management, LLC 3.77M Mar 31, 2026 1.92% $0.00 2.57%
ADAR1 Capital Management LLC 3.13M Mar 31, 2026 1.59% $0.83 -42.14%
Adage Capital Partners Gp LLC 2.66M Mar 31, 2026 1.35% $0.02 -38.60%
BlackBarn Capital Partners LP 2.50M Mar 31, 2026 1.27% $0.91 35.14%
Legal & General Group PLC 2.40M Mar 31, 2026 1.22% $0.00 1,856.15%
Woodline Partners LP 2.01M Mar 31, 2026 1.02% $0.03 -8.07%
Bank of America Corp 1.68M Mar 31, 2026 0.85% $0.00 -8.13%
Charles Schwab Investment Management Inc 1.40M Mar 31, 2026 0.71% $0.00 -10.31%
Advisor Group Holdings, Inc. 1.35M Mar 31, 2026 0.68% $0.01 -0.01%
Northern Trust Corp 1.28M Mar 31, 2026 0.65% $0.00 3.33%
The Goldman Sachs Group Inc 1.10M Mar 31, 2026 0.56% $0.00 48.99%
Citigroup Inc 898.42K Mar 31, 2026 0.46% $0.00 47.01%

Shares Statistics

Shares Outstanding: 197.54M
Shares Float: 121.37M
% Insiders: 2,045.90%
% Institutions: 7,190.70%
Short % Float: 12.38%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard Total Stock Mkt Idx Inv 4.81M 2.44% ▲ 0.00% Apr 30, 2026
2 Morgan Stanley Insight I 3.83M 1.95% ▼ 2.59% Mar 31, 2026
3 Morgan Stanley Insight 3.83M 1.95% ▼ 2.59% Mar 31, 2026
4 iShares Russell 2000 ETF 3.58M 1.82% ▲ 0.85% Apr 30, 2026
5 MS INVF Global Insight Z 2.50M 1.27% ▲ 0.00% Dec 31, 2025
6 State Street® SPDR® S&P® Biotech ETF 2.47M 1.25% ▼ 0.74% Apr 30, 2026
7 Morgan Stanley Inst Inception I 2.03M 1.03% ▼ 5.66% Mar 31, 2026
8 Morgan Stanley Inception 2.03M 1.03% ▼ 5.66% Mar 31, 2026
9 Vanguard Institutional Extnd Mkt Idx Tr 1.74M 0.89% ▲ 0.65% Apr 30, 2026
10 Fidelity Small Cap Index 1.48M 0.75% ▲ 1.13% Feb 28, 2026

Valuation Metrics

Enterprise Value: $787.41M
Trailing P/E: 5.13
Forward P/E: 10.25

Financial Highlights

Market Cap: $841.51M
EBITDA: $155.14M
P/E Ratio: $5.13
PEG Ratio: $0.00
Book Value: $1.32
Earnings/Share: $0.83
Profit Margin: 83.95%
Operating Margin: 94.41%
ROA (TTM): 49.18%
ROE (TTM): 94.73%
Revenue (TTM): $191.44M
Revenue/Share (TTM): $1.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 10,054.50%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 15.73x 0.01x 0.19x -278.88x -0.02x
2024-12-31 8.15x 0.00x 0.26x -557.07x -0.01x
2023-12-31 5.87x 0.00x 0.27x -170.16x -0.01x
2022-12-31 4.60x 0.00x 0.30x -37.92x -0.01x
2021-12-31 14.32x 0.00x 0.17x -25.73x -0.01x
2020-12-31 13.38x 0.00x 0.26x -14.41x -0.01x
2019-12-31 11.99x 0.00x 0.31x -68.26x 0.00x
2018-12-31 11.50x 0.00x 0.12x -449.00x 0.00x
2017-12-31 10.87x 0.10x 0.23x -424.90x -0.17x
2016-12-31 12.51x 0.09x 0.26x -353.41x -0.04x
2015-12-31 17.38x 0.01x 0.23x -151.81x -0.08x
2014-12-31 8.08x 0.02x 0.26x -38.69x -0.05x
2013-12-31 5.62x 0.04x 0.17x -22.51x -0.21x
2012-12-31 4.68x 0.07x 0.22x -276.43x 0.09x
2011-12-31 1.69x 0.00x 0.62x -134.23x 0.00x
2010-12-31 2.20x 0.00x 0.49x -117.01x 0.00x
2009-12-31 3.81x 0.00x 0.16x -57.99x 0.00x
2008-12-31 6.74x 0.08x 0.10x N/A -0.41x
2007-12-31 3.60x 0.01x 0.26x 2.58x 0.05x
2006-12-31 0.95x 0.95x 0.97x -1.05x 0.01x
2005-12-31 4.94x -1.87x 2.00x N/A 26.40x
2004-12-31 2.64x -3.14x 1.26x N/A -1.84x
2003-12-31 8.84x 0.03x 0.14x N/A -0.04x
2002-12-31 8.11x 0.01x 0.15x N/A -0.01x
2001-12-31 19.27x 0.01x 0.09x N/A -0.03x
2000-12-31 13.24x 0.00x 0.08x N/A -0.01x
1999-12-31 15.28x 0.00x 0.07x N/A 0.00x
1998-12-31 8.21x 0.00x 0.09x N/A 0.00x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about ABUS.US!